Hoffmans

The Toro Company and The Hoffman Family Foundation Announce Gift to the University of St. Thomas in Honor of Kendrick B. Melrose

Retrieved on: 
Friday, July 31, 2020

Melrose, who preceded Hoffman as TTCs chairman and CEO, successfully led the company for nearly 25 years until retiring in 2006.

Key Points: 
  • Melrose, who preceded Hoffman as TTCs chairman and CEO, successfully led the company for nearly 25 years until retiring in 2006.
  • This gift will establish the Melrose & The Toro Company Center for Principled Leadership at the Opus College of Business and includes a $2 million donation by The Toro Foundation, along with a $1 million donation from the Hoffmans.
  • This cause was important to Melrose, who championed the concept through Leading by Serving, LLC, an organization he founded in 2006.
  • Ken Melrose was an extraordinary person and a very important figure in our companys history, said Richard Olson, current chairman and CEO of The Toro Company.

Diamond Hill Appoints Asset Management Executive Lara Hoffmans, CFA, as Managing Director, Marketing; Names Jo Ann Quinif Chief Client Officer

Retrieved on: 
Tuesday, January 21, 2020

Hoffmans brings 19 years of asset and wealth management experience to Diamond Hill.

Key Points: 
  • Hoffmans brings 19 years of asset and wealth management experience to Diamond Hill.
  • She will report to Jo Ann Quinif, who has been named chief client officer, also a new position.
  • Quinif, who joined Diamond Hill in 2017, previously served as managing director, business development and marketing.
  • "Jo Ann is the first executive at Diamond Hill to serve as chief client officer, and her new title is well-deserved recognition of her leadership skills and responsibilities.

Rockwell Medical, Inc. Expands Medical Capabilities

Retrieved on: 
Wednesday, November 20, 2019

WIXOM, Mich., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI) (Rockwell Medical or the Company), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced that the Company is expanding its medical capabilities, with the initial goal of building a leading medical organization in the field of dialysis.

Key Points: 
  • WIXOM, Mich., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI) (Rockwell Medical or the Company), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced that the Company is expanding its medical capabilities, with the initial goal of building a leading medical organization in the field of dialysis.
  • As a result, the Company is making investments in its medical organization, real-world data and medical educational programs, and clinical development capabilities.
  • With the establishment of these priorities, Rockwell Medical has appointed Marc Hoffman, MD as Chief Medical Officer (CMO).
  • Dr. Hoffmans skillset will complement the Companys existing medical capabilities and enable the Company to drive these key medical priorities.